ADMP - アダミス・ファ―マス―ティカルズ (Adamis Pharmaceuticals Corporation) アダミス・ファ―マス―ティカルズ

 ADMPのチャート


 ADMPの企業情報

symbol ADMP
会社名 Adamis Pharmaceuticals Corp. (アダミス・ファ―マス―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company''s product portfolio includes specialty pharmaceutical products such as Epinephrine pre-filled syringe (PFS) APC-5000 dry powder inhaler (DPI) APC-1000 and APC-2000 and biotechnology products such as TeloB-VAX (vaccine) APC-100 APC-200 and APC-300. The Company''s lead product candidate the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe or the Epinephrine PFS is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.   アダミス・ファ―マス―ティカルズは米国の医薬品会社。アナフィラキシ―(急性の全身過敏症)、喘息、慢性閉塞性肺疾患、アレルギ―性鼻炎治療のネピネフリン自己注射剤、ドライパウダ―吸入器、吸入ステロイド薬の治験を行う。また、前立腺がんのテロメラ―ゼ阻害剤を治験中。本社はカリフォルニア州サンディエゴ。   Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
本社所在地 11682 El Camino Real Suite 300 San Diego CA 92130 USA
代表者氏名 Richard C. Williams リチャード・C・ウィリアムズ
代表者役職名 Independent Chairman of the Board
電話番号 +1 858-997-2400
設立年月日 32660
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 126人
url www.adamispharmaceuticals.com
nasdaq_url https://www.nasdaq.com/symbol/admp
adr_tso
EBITDA EBITDA(百万ドル) -28.29893
終値(lastsale) 3.09
時価総額(marketcap) 146130296.22
時価総額 時価総額(百万ドル) 144.23860
売上高 売上高(百万ドル) 13.32986
企業価値(EV) 企業価値(EV)(百万ドル) 145.65953
当期純利益 当期純利益(百万ドル) -22.70772
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Adamis Pharmaceuticals Corp revenues increased 4% to $7.1M. Net loss increased 61% to $17.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $2.7M to $7.1M (expense) Selling general_administrative expense increase of 14% to $12.8M (expense).

 ADMPのテクニカル分析


 ADMPのニュース

   Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock  2020/09/17 20:05:00 GlobeNewswire
SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on…
   Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update  2020/08/17 16:40:00 Benzinga
SAN DIEGO, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced financial results for the second …
   Adamis Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement  2020/08/05 20:05:00 GlobeNewswire
SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has received a letter from the…
   The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter  2020/07/30 08:09:00 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp …
   Why Adamis Pharma's Stock Is Trading Higher Today  2020/06/15 15:23:35 Benzinga
Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) shares are trading higher on Monday. The company announced a license to commercialize Tempol, a patented investigational drug for the treatment of coronavirus and respiratory disease. Adamis Pharmaceuticals is … Full story available on Benzinga.com
   Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock  2020/09/17 20:05:00 GlobeNewswire
SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on…
   Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update  2020/08/17 16:40:00 Benzinga
SAN DIEGO, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced financial results for the second …
   Adamis Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement  2020/08/05 20:05:00 GlobeNewswire
SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has received a letter from the…
   The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter  2020/07/30 08:09:00 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp …
   Why Adamis Pharma's Stock Is Trading Higher Today  2020/06/15 15:23:35 Benzinga
Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) shares are trading higher on Monday. The company announced a license to commercialize Tempol, a patented investigational drug for the treatment of coronavirus and respiratory disease. Adamis Pharmaceuticals is … Full story available on Benzinga.com
   Adamis Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement  2020/08/05 20:05:00 GlobeNewswire
SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has received a letter from the…
   The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter  2020/07/30 08:09:00 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp …
   Why Adamis Pharma's Stock Is Trading Higher Today  2020/06/15 15:23:35 Benzinga
Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) shares are trading higher on Monday. The company announced a license to commercialize Tempol, a patented investigational drug for the treatment of coronavirus and respiratory disease. Adamis Pharmaceuticals is … Full story available on Benzinga.com
   Thinking about buying stock in TOP Ships, Hertz, Biocept, Edesa Biotech, or Adamis Pharmaceuticals?  2020/06/15 14:30:00 PR Newswire
NEW YORK, June 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TOPS, HTZ, BIOC, EDSA, and ADMP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant Drug for the Treatment of Respiratory Diseases Including COVID-19  2020/06/15 13:00:00 GlobeNewswire
SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today a license to commercialize…

 関連キーワード  (医薬品 米国株 アダミス・ファ―マス―ティカルズ ADMP Adamis Pharmaceuticals Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)